-
Mashup Score: 4
Olivieri DJ, Othus M, Orvain C, et al. Impact of Socioeconomic Disparities on Outcomes in Adults Undergoing Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia. Leukemia….
Source: www.astct.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 5
Join ASTCT Director of Government Relations, Alycia Maloney, JD, and the reimbursement and policy advisors to ASTCT from Nimitt Consulting, for the Medicare FY 2025 IPPS Proposed Rule webinar on May 15 at 12 p.m. CDT. Maloney and Nimitt will cover multiple CMS proposals for FY 2025, including the following key points: Proposed increases to the MS-DRG base payment rates for stem cell transplant and CAR-T/Other Immunotherapy inpatient Medicare cases, including the following: Allogeneic HSCT (DRG 014)
Source: learn.astct.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 12ASTCT Talks: Beyond Remission: Navigating the Late Effects of Pediatric CAR T-Cell Therapy - 5 day(s) ago
In this episode “ASTCT Talks,” hosts Rebecca Epperly, MD, and Aimee Talleur, MD, from St. Jude Children’s Research Hospital, dive into the pioneering realm of CAR T-cell therapy and…
Source: www.astct.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 14
Saha A, Palchaudhuri R, Lanieri L, et al. Alloengraftment Without Significant Toxicity or GVHD in CD45 Antibody-Drug Conjugate Conditioned Fanconi Anemia Mice. Blood. 2024; (doi:…
Source: www.astct.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 4ASTCT Learning Center: Impact of Subspecialty Palliative Care Consultation in Transplantation and Cellular Therapy - 7 day(s) ago
This webinar is the second in a series of three presented by the ASTCT Palliative Care SIG. In this session, the speakers will review the evidence base on subspecialty palliative care for improving outcomes in patients undergoing hematopoietic stem cell transplantation and adoptive cellular therapy, and also review the active components of palliative care interventions and how to best integrate them into practice. Dr. Thomas W. LeBlanc, MD, MA, MHS, FAAHPM, FASCO Associate Professor of Medicine with
Source: learn.astct.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 5
Join ASTCT Director of Government Relations, Alycia Maloney, JD, and the reimbursement and policy advisors to ASTCT from Nimitt Consulting, for the Medicare FY 2025 IPPS Proposed Rule webinar on May 15 at 12 p.m. CDT. Maloney and Nimitt will cover multiple CMS proposals for FY 2025, including the following key points: Proposed increases to the MS-DRG base payment rates for stem cell transplant and CAR-T/Other Immunotherapy inpatient Medicare cases, including the following: Allogeneic HSCT (DRG 014)
Source: learn.astct.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 19
Date: May 22nd (Wednesday) Time: 3 pm Pacific / 6 pm Eastern Where: Online Program GVHD is a potentially life-threatening condition affecting an estimated 50% of blood cancer patients who receive stem cell transplants from a donor. Join us for an informative discussion as transplant experts explain GVHD risks, how to watch for symptoms, the […]
Source: thepatientstory.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 1Addressing Disparities and Improving Supportive Care in Hematopoietic Stem Cell Transplantation - 10 day(s) ago
Although scientific progress in HSCT is ongoing, gaps remain in both access to care and outcomes. An Education Session will review the latest research on overcoming disparities and managing psychosocial and symptom interventions.
Source: dailynews.ascopubs.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 3ASTCT Learning Center: Pharmacy HCT Core Topics Spring 2024 Live Session - Immunosuppression Management and HCT Complications - 15 day(s) ago
The Pharmacy HCT Core Topics Live Session will air on Wednesday, May 8, at 2 pm CT/3 pm ET. This live session will focus on two core topics in hematopoietic cell transplantation and cellular therapy- Immunosuppression management and HCT complications. The faculty below will answer questions about their respective topics and share their experiences from their institutions. The target audience is PGY2 Oncology Pharmacy Residents, but is open to all trainees practicing or interested in transplantation and
Source: learn.astct.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 2Tissue-infiltrating alloreactive T cells require Id3 to deflect PD-1–mediated immune suppression during GVHD - 16 day(s) ago
Researchers have discovered a significant function of the Id3 protein in the persistence and operational capabilities of tissue-infiltrating alloreactive T cells, offering insights that could…
Source: www.astct.orgCategories: General Medicine News, Onc News and JournalsTweet
Socioeconomic disparities may narrow access to #alloHCT among patients with acute myeloid leukemia, but new research suggests these factors have little impact on post-transplant outcomes. Read more on Nucleus: https://t.co/3bFsHIqKot #AML #Leusm https://t.co/6WQXPINaQe